| Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation F Garcia Soriano, L Virag, P Jagtap, E Szabo, JG Mabley, L Liaudet, ... Nature medicine 7 (1), 108-113, 2001 | 791 | 2001 |
| Document Biology of nitric oxide signaling L Liaudet, FG Soriano, C Szabó Critical Care Medicine 28 ((4 SUPPL.)), N37-N52, 2000 | 540 | 2000 |
| Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: IκBα degradation, induction of nitric oxide synthase, induction of … T Eaves-Pyles, K Murthy, L Liaudet, L Virág, G Ross, FG Soriano, ... The Journal of Immunology 166 (2), 1248-1260, 2001 | 388 | 2001 |
| The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes P Pacher, L Liaudet, FG Soriano, JG Mabley, E Szabo, C Szabo Diabetes 51 (2), 514-521, 2002 | 372 | 2002 |
| Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study DT Noritomi, FG Soriano, JA Kellum, SB Cappi, PJC Biselli, AB Libório, ... Critical care medicine 37 (10), 2733-2739, 2009 | 281 | 2009 |
| Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP-ribose) polymerase FG Soriano, P Pacher, J Mabley, L Liaudet, C Szabó Circulation research 89 (8), 684-691, 2001 | 262 | 2001 |
| Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase L Liaudet, FG Soriano, É Szabó, L Virág, JG Mabley, AL Salzman, ... Proceedings of the National academy of Sciences 97 (18), 10203-10208, 2000 | 258 | 2000 |
| Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents P Jagtap, FG Soriano, L Virág, L Liaudet, J Mabley, É Szabó, G Haskó, ... Critical care medicine 30 (5), 1071-1082, 2002 | 247 | 2002 |
| Activation of poly (ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation L Liaudet, PÁL Pacher, JG Mabley, L Virág, FG Soriano, G Haskó, ... American journal of respiratory and critical care medicine 165 (3), 372-377, 2002 | 246 | 2002 |
| Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition … C Szabó, JG Mabley, SM Moeller, R Shimanovich, P Pacher, L Virág, ... Molecular Medicine 8, 571-580, 2002 | 226 | 2002 |
| Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases NA Berger, VC Besson, AH Boulares, A Bürkle, A Chiarugi, RS Clark, ... British journal of pharmacology 175 (2), 192-222, 2018 | 203 | 2018 |
| Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADP-ribose) polymerase activation F Soriano, L Virág, C Szabó Journal of molecular medicine 79, 437-448, 2001 | 201 | 2001 |
| Resistance to acute septic peritonitis in poly (ADP-ribose) polymerase-1-deficient mice FG Soriano, L Liaudet, E Szabo, L Virág, JG Mabley, P Pacher, C Szabo Shock 17 (4), 286-292, 2002 | 191 | 2002 |
| Clinical review: Hypertonic saline resuscitation in sepsis RP Oliveira, I Velasco, FG Soriano, G Friedman Critical care 6, 1-6, 2002 | 184 | 2002 |
| Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase JG Mabley, P Jagtap, M Perretti, SJ Getting, AL Salzman, L Virag, ... Inflammation Research 50, 561-569, 2001 | 173 | 2001 |
| Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis L Liaudet, C Szabó, OV Evgenov, KG Murthy, P Pacher, L Virág, ... Shock 19 (2), 131-137, 2003 | 163 | 2003 |
| Diabetes induces apoptosis in lymphocytes R Otton, FG Soriano, R Verlengia, R Curi Journal of Endocrinology 182 (1), 145-156, 2004 | 149 | 2004 |
| Potential role of poly (adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock FG Soriano, AC Nogueira, EG Caldini, MH Lins, AC Teixeira, SB Cappi, ... Critical care medicine 34 (4), 1073-1079, 2006 | 141 | 2006 |
| The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis J Mabley, F Soriano, P Pacher, G Haskó, A Marton, R Wallace, A Salzman, ... European journal of pharmacology 466 (3), 323-329, 2003 | 140 | 2003 |
| Impact of BAL in the management of pneumonia with treatment failure: positivity of BAL culture under antibiotic therapy JCP Gomes, WL Pedreira Jr, EMPA Arauójo, FG Soriano, EM Negri, ... Chest 118 (6), 1739-1746, 2000 | 132 | 2000 |
Csaba SzaboProfessor, Chair of Pharmacology, University of Fribourg, Switzerland在 unifr.ch 的电子邮件经过验证
